- Programme
- Horizon 2020 & sub-programmes
- Duration
- 72 months (April 2019 – March 2025)
- Project funding
- ≈ €22 million
- Project partners
- 34
- Project website
- Visit project website
What the project is about
The main aim of the IMI project BIOMAP is to improve the lives of patients affected by the two most common inflammatory skin conditions. Addressing key unmet needs in treating atopic dermatitis and psoriasis, the five-year project will have a broad impact on disease understanding, patient care and future therapies. The team comprises 27 academic and seven pharma partners as well as six patient organisations.
Your EURICE contacts
Your contact
Tamara Messer
Senior Research & Impact Manager
Explore THE COURT
Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.
Enter THE COURT